leucine and Mucocutaneous Lymph Node Syndrome

leucine has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Agostini, H; Belot, A; Boukhedouni, N; Dusser, P; Foell, D; Fuehner, S; Kessel, C; Koné-Paut, I; Marie, I; Masjosthusmann, K; Piedvache, C; Rossi-Semerano, L; Tellier, S; Wittkowski, H1

Other Studies

1 other study(ies) available for leucine and Mucocutaneous Lymph Node Syndrome

ArticleYear
An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial.
    Journal of clinical immunology, 2022, Volume: 42, Issue:6

    Topics: Biomarkers; Child; Endothelial Cells; Glycoproteins; Humans; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Interleukin-6; Leucine; Mucocutaneous Lymph Node Syndrome; Retrospective Studies; S100A12 Protein

2022